Álvarez DHT, Savigne GWO, Fernández MJI, Jay CVG

Language: Spanish
References: 11
Page: 1-8
PDF size: 261.40 Kb.

ABSTRACT

In December, 2019 in the Chinese city of Wuhan were reported the first cases of a new disease associated to SARS-CoV-2, called COVID-19 and it was declared as a pandemic by WHO. This disease had high lethality in patients older than 60 years whom in some cases reported predisposition to develop microthrombosis and/or thrombosis in the arterial and venous system. Cuba presented its first case in April, 2020 with a similar behaviour, then our health system implemented effective measures and put into practice all the knowledge accumulated by the scientific community. In this sense, it is presented a scientific interest case of ischemic gangrene of low limb in a patient with COVID-19. The 42 years old female patient was diagnosed with COVID-19 and other comorbidities, as well as with a severe acute respiratory condition, associated to a microthrombosis process and lesions of distal ischemic grangrene of left low limb´s toes, due to the microthrombosis related with excesive inflammation, platelets activation, endothelial dysfunction and stasis. Thanks to the protocols applied in Cuba, the patient survived to those complications. This case shows a complication that is not fully described to the moment, something which must be reported and known as theoric-practical scientific interest of our health professionals.

REFERENCES

1. Shaolin H, Yeming W, Xingwang L, Lili R, Jianping Z, Yi H, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

2. Can T, Seyhan T, Sena Temirci E, Yavuz Malkan U, Haznedaroglu ÍC. COVID-19 and the Renin-Angiotensin-Aldosterone System. 2020 Apr-Jun. DOI: https://doi.org/10.1177/1470320320928872

3. Gonaglea D, Sharifa K, O'Regand A, Bridgewood Ch. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmunity Reviews. 2020. DOI: https://doi.org/10.1016/j.autrev.2020.102537

4. Bikdeli B, Madhavan Mahesh V, Jimenez D, Chuich T. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy and Follow-up. Journal of the American College of Cardiology. 2020. DOI. https://doi.org/10.106/j.jacc202004.031

5. Moores LK, Tritschler T, Brosnahan Sh, Carrier M, Collen JF. Prevention, Diagnosis and Treatment of VTE in Patients with COVID-19. CHEST Guideline and Expert Panel Report. 2020. DOI: https://doi.org/10.1016/j.chest.2020.05.559

6. Qun L, Xuhua G, Peng W, Xiaoye W, Lei Zh, Yeqing T, et al. Early Transmission Dynamics in Wuhan, China of Novel Coronavirus-Infected Pneumonia. The New England Journal of Medicine. 2020;382:1199-207. DOI: https://doi.org/10.1056/NEJMoa2001316

7. Riveron-Cruzata LJ, Vergara-Silva M, Lluch-Pena AP, Alba-Cutino Y, Ortiz-Rodríguez AY. Pacientes sospechosos de COVID-19 con RT-PCR negativo atendidos en un centro de aislamiento en Las Tunas. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta. 2020 Jul-Ago [acceso 25/07/2020];45(4). Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/2304

8. MINSAP. Coranovirus en Cuba, Información Oficial del MINSAP. La Habana: MINSAP; 2020 [acceso 25/07/2020]. Disponible en: https://salud.msp.gob.cu

9. Moores Lisa K, Tritschler T, Brosnahan Sh, Carrier M, Collen Jacob F, Doerschug K, et al. Prevention, Diagnosis and Treatment of VTE in Patients With COVID-19. CHEST Guideline and Expert Panel Report. 2020 Jun 23. DOI: https://doi.org/10.1016/j.chest.2020.05.559

10. Behnood B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, et al. Covid-19 y tromboembolismos venosos y arteriales. J Am Coll Cardiol. 2020 Jun 16;75(23):2950-73. DOI: https://doi.org/10.1016/j.jacc.2020.04.031

11. MINSAP. Protocolo de actuación nacional para la COVID-19. La Habana: MINSAP; 2020 [acceso 25/07/2020]. Disponible en: https://salud.msp.gob.cu